Proteome Sciences plc (PMSNF)
OTCMKTS · Delayed Price · Currency is USD
0.0449
-0.0051 (-10.20%)
At close: Jun 17, 2025
Proteome Sciences Market Cap
Proteome Sciences has a market cap or net worth of $13.86 million as of September 5, 2025. Its market cap has increased by 9.28% in one year.
Market Cap
13.86M
Enterprise Value
31.98M
Revenue
6.12M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.04
Market Cap Chart
Since September 17, 1997, Proteome Sciences's market cap has decreased from 44.10M to 13.86M, a decrease of -68.57%. That is a compound annual growth rate of -4.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 13.86M | 10.31% |
| Dec 31, 2024 | 12.56M | -26.23% |
| Dec 29, 2023 | 17.03M | 36.83% |
| Dec 30, 2022 | 12.45M | -39.23% |
| Dec 31, 2021 | 20.48M | 31.34% |
| Dec 31, 2020 | 15.60M | 35.70% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 840.66M |
| Elite Pharmaceuticals | 757.64M |
| Tian'an Technology Group | 660.01M |
| Glass House Brands | 561.06M |
| Northwest Biotherapeutics | 393.37M |
| CytoDyn | 391.17M |
| American Oncology Network | 361.55M |